These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 26703343)

  • 1. [Mucolytic and antioxidant agents for exacerbations of chronic obstructive pulmonary disease: A meta-analysis].
    Li X; Sun H; Liu C; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Aug; 38(8):600-6. PubMed ID: 26703343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
    Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
    Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.
    Poole PJ; Black PN
    Am J Respir Med; 2003; 2(5):367-70. PubMed ID: 14719989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Shen Y; Cai W; Lei S; Zhang Z
    COPD; 2014 Jun; 11(3):351-8. PubMed ID: 24378052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose N-acetylcysteine in the prevention of COPD exacerbations: rationale and design of the PANTHEON Study.
    Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Xia QK; Gao Y; Zhong NS;
    COPD; 2013 Apr; 10(2):164-71. PubMed ID: 23061828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.
    Poole PJ; Black PN
    BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
    Wang J; Nie B; Xiong W; Xu Y
    J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: systematic review and meta-analyses.
    Shah V; Taddio A; Rieder MJ;
    Clin Ther; 2009; 31 Suppl 2():S104-51. PubMed ID: 19781433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
    Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
    Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review.
    Fowdar K; Chen H; He Z; Zhang J; Zhong X; Zhang J; Li M; Bai J
    Heart Lung; 2017; 46(2):120-128. PubMed ID: 28109565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis.
    Yang M; Chen H; Zhang Y; Du Y; Xu Y; Jiang P; Xu Z
    Inhal Toxicol; 2017 Apr; 29(5):219-226. PubMed ID: 28714745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
    Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
    Rodrigo GJ; Price D; Anzueto A; Singh D; Altman P; Bader G; Patalano F; Fogel R; Kostikas K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():907-922. PubMed ID: 28360514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.